comprehensive -WSS

comprehensive

author：leisure time 2025-09-14 06:48:12 - browse：5311

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Eli Lilly to acquire Versanis in heated race for weight loss drugs

Wikipedia

WSS

Can food be medicine? And other questions about a new push

Why is France rioting? What to know about the fatal police shooting of Nahel M

Did the public have the right to know Arthur Ashe had AIDS?

These geoengineering technologies could help combat the climate crisis, scientists say

Australia's humpback populations rebound raising hopes of marine scientists

Community addresses injustice for Long Island mothers

Wikipedia

comprehensive

hotspot

How one medical school became remarkably diverse

Inside the fall of star MIT scientist David Sabatini

Trump demands the U.S. pay no more for drugs than other countries … again

Care demand spikes challenge UnitedHealth’s provider arm

Hepatitis C has a cure — but many Americans still lack access to it

These geoengineering technologies could help combat the climate crisis, scientists say

Apple is now the first public company to be valued at $3 trillion

Grail is spending more than ever lobbying Congress

Novavax promises a turnaround & Lilly roils the obesity market

7 people shot in DC, police say

hotspot

New case study details death in closely watched Alzhiemer's trial

Federal judge rules Oregon’s tough new gun law is constitutional

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Celiac disease study examines precisely how gluten triggers injury

7 people shot in DC, police say

explore

Wikipedia

explore

focus